[Molecular and cellular bases of cytostatic therapy].
D000903:Antibiotics, Antineoplastic / Q000494:pharmacology* / Q000627:therapeutic use; D000963:Antimetabolites / Q000494:pharmacology; D001215:Asparaginase / Q000378:metabolism / Q000494:pharmacology; D001216:Asparagine / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects*; D002460:Cell Line; D002477:Cells / Q000187:drug effects; D004247:DNA / Q000096:biosynthesis / Q000378:metabolism; D004273:DNA, Neoplasm / Q000096:biosynthesis / Q000378:metabolism; D006801:Humans; D008727:Methotrexate / Q000494:pharmacology; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D009584:Nitrogen / Q000378:metabolism; D014176:Protein Biosynthesis; D012313:RNA / Q000096:biosynthesis; D012334:RNA, Neoplasm / Q000096:biosynthesis
D000903:Antibiotics, Antineoplastic; D000963:Antimetabolites; D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; D012313:RNA; D001216:Asparagine; D004247:DNA; D001215:Asparaginase; D009584:Nitrogen; D008727:Methotrexate
Molekulare und zelluläre Grundlagen der zytostatischen Therapie.